Tags

Type your tag names separated by a space and hit enter

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines.
Mol Ther. 2020 Nov 04; 28(11):2303-2304.MT

Links

PMC Free PDF

Authors+Show Affiliations

Kremer EJ
Institut de Génétique Moléculaire de Montpellier, University of Montpellier - CNRS, Montpellier, France. Electronic address: eric.kremer@igmm.cnrs.fr.

MeSH

Adenovirus VaccinesAnimalsBetacoronavirusCOVID-19COVID-19 VaccinesCoronavirus InfectionsHumansPandemicsPneumonia, ViralSARS-CoV-2Viral Vaccines

Pub Type(s)

Editorial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

33065038

Citation

Kremer, Eric J.. "Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines." Molecular Therapy : the Journal of the American Society of Gene Therapy, vol. 28, no. 11, 2020, pp. 2303-2304.
Kremer EJ. Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines. Mol Ther. 2020;28(11):2303-2304.
Kremer, E. J. (2020). Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy, 28(11), 2303-2304. https://doi.org/10.1016/j.ymthe.2020.10.002
Kremer EJ. Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines. Mol Ther. 2020 Nov 4;28(11):2303-2304. PubMed PMID: 33065038.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines. A1 - Kremer,Eric J, Y1 - 2020/10/09/ PY - 2020/10/17/pubmed PY - 2020/12/1/medline PY - 2020/10/16/entrez SP - 2303 EP - 2304 JF - Molecular therapy : the journal of the American Society of Gene Therapy JO - Mol Ther VL - 28 IS - 11 SN - 1525-0024 UR - https://www.unboundmedicine.com/medline/citation/33065038/Pros_and_Cons_of_Adenovirus_Based_SARS_CoV_2_Vaccines_ DB - PRIME DP - Unbound Medicine ER -